25. Immunogenicity and Reactogenicity of COVID-19 mRNA Vaccines in Allogeneic Stem Cell Transplant Recipients

BACKGROUND: Allogeneic stem cell transplant (SCT) recipients are at an increased risk of poor outcomes from COVID-19. While the mRNA-1273 (Moderna) and BNT162b2 (Pfizer) COVID-19 mRNA vaccines are highly immunogenic in the general population, the immune response in SCT recipients is poorly understoo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bausk, Bruce P, Sherman, Amy C, Desjardins, Michaël, Izaguirre, Natalie E, Cheng, Chi-An, Powell, Megan, Senussi, Yasmeen, Gilboa, Tal, Krauss, Jonathan H, Dirr, Bonnie, Power, Elyssa, Joyce, Amy, Stewart, Lisa, Ometoruwa, Omolola, Novack, Lewis A, Evans, Bethany, Woods, Tenaizus, Tong, Alexandra, Walt, David, Soiffer, Robert, Ho, Vincent T, Issa, Nicolas C, Baden, Lindsey R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Oral Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644500/
http://dx.doi.org/10.1093/ofid/ofab466.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644500/
http://dx.doi.org/10.1093/ofid/ofab466.025

Ejemplares similares